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ABSTRACT
A polymorphism of rs4245739 has been associated to susceptibility of several 
cancers, including ER-negative breast cancer.  rs4245739 is located at the 3’UTR 
of MDM4 gene, an oncogene that negatively regulates p53. The polymorphism 
has been associated to the binding changes of miR-191. We studied the influence 
of SNP rs4245739 to the binding of microRNAs, expression of microRNAs, and 
MDM4. Using FindTar software, we detected the potential microRNAs affected by 
SNP-flanking sequence. The RNA sequencing data from ER-negative breast cancer 
were collected to compare the expression of miR-184, miR-191, miR-193a, miR-
378, and MDM4 in different genotypes. Comparison of ER-negative patients with 
positive or negative expression of miR-191, as well as the profile of microRNAs 
(miR-184, miR-191, miR-193a and miR-378 altogether) might differentiate the 
expression of MDM4 various alleles. In addition, the number of lymphatic nodes 
affected in the individuals was also found to be significantly reduced in the risk group 
according to the data obtained by the miRNA profiling method. We concluded that 
our methods, especially the miRNA profiling approach, are useful in obtaining new 
molecular and clinical features related to the rs4245739 SNP, a variant located in 
the 3’UTR of MDM4 gene known to appear in different types of cancer.
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